TISLELIZUMAB-JSGR for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TISLELIZUMAB-JSGR was used for Prophylaxis.
Most Reported Side Effects for TISLELIZUMAB-JSGR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 15 | 30.0% | 2 | 0 |
| Off label use | 9 | 18.0% | 2 | 1 |
| Anaemia | 8 | 16.0% | 1 | 1 |
| Pneumonia | 8 | 16.0% | 2 | 7 |
| Lymphadenopathy | 7 | 14.0% | 0 | 0 |
| Thrombocytopenia | 7 | 14.0% | 0 | 0 |
| Infusion related reaction | 6 | 12.0% | 0 | 6 |
| Pyrexia | 6 | 12.0% | 0 | 5 |
| Death | 5 | 10.0% | 5 | 0 |
Other Indications for TISLELIZUMAB-JSGR
Oesophageal adenocarcinoma (13)
Oesophageal squamous cell carcinoma (11)
Product used for unknown indication (10)
Richter's syndrome (9)
Chronic lymphocytic leukaemia (8)
Diffuse large b-cell lymphoma (8)
Gastrooesophageal reflux disease (6)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)